Symic Biomedical

About:

SYMIC Biomedical operates in the healthcare industry focusing on biotechnology business.

Website: http://www.symic.bio/

Twitter/X: symicbio

Top Investors: Mission BioCapital, National Science Foundation, National Institutes of Health, Mitsui Global Investment, ReproCELL

Description:

Symic Biomedical is a developer of matrix regulator therapeutics designed to affect matrix degradation and structure. The company's therapeutics bind to targets in the matrix, damaged in response to injury or because of disease, to inhibit pathological inflammatory responses, enabling clinicians to investigate applications in the areas of fibrosis, oncology and diseases of the central nervous system.